Renal Diseases and Glomerulopathies

Renal Diseases and Glomerulopathies is a research topic within Nephrology. Science Explorer counts 37k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the pathophysiology, genetics, and clinical aspects of glomerular diseases, including nephrotic syndromes such as membranous nephropathy, focal segmental glomerulosclerosis, and IgA nephropathy. It covers topics such as podocyte biology, renal thrombotic microangiopathy, genetic kidney diseases, and the role of the kidney barrier function in disease development.

Glomerular Diseases
Nephrotic Syndrome
Podocyte Biology
Membranous Nephropathy
Focal Segmental Glomerulosclerosis
IgA Nephropathy
Renal Thrombotic Microangiopathy
Podocyte Depletion
Genetic Kidney Diseases
Kidney Barrier Function

Research works: 37k
In the world top 10%: 3.7k
Top-10% rate: 10.0%
Growth, 2018-21 → 2022-25: +22%
Largest producer: United States

Renal Diseases and Glomerulopathies

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Renal Diseases and Glomerulopathies research?

By volume, the United States and China publish the most (1.7k and 1.5k works in 2022-now).

By volume, 2022-now

1 United States 1.7k works
2 China 1.5k works
3 Japan 553 works
4 India 469 works
5 Germany 302 works
6 United Kingdom 294 works
7 Italy 259 works
8 France 213 works
9 Spain 204 works
10 Canada 150 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States1,707 · 30.2%China1,508 · 26.7%Japan553 · 9.8%India469 · 8.3%6 others listed1,421 · 25.1%

Shares of the rows listed above, not of the whole node.

Which institutions lead Renal Diseases and Glomerulopathies research?

By volume in 2022-now, Harvard University publishes the most Renal Diseases and Glomerulopathies research, followed by Peking University and Mayo Clinic.

By volume, 2022-now

1 Harvard UniversityUnited States 76 works
2 Peking UniversityChina 72 works
3 Mayo ClinicUnited States 60 works
4 Shanghai Jiao Tong UniversityChina 45 works
5 Sun Yat-sen UniversityChina 42 works
6 All India Institute of Medical SciencesIndia 42 works
7 Zhejiang UniversityChina 39 works
8 InsermFrance 38 works
9 Universität HamburgGermany 36 works
10 Nanjing Medical UniversityChina 36 works

Who are the leading researchers in Renal Diseases and Glomerulopathies?

The most-cited researchers publishing on Renal Diseases and Glomerulopathies include George Davey Smith, Mark J. Daly and John J.V. McMurray.

1 George Davey Smith United Kingdom 435k citations
2 Mark J. Daly United States 403k citations
3 John J.V. McMurray United Kingdom 349k citations
4 Hermann Brenner Germany 343k citations
5 Shizuo Akira Japan 342k citations
6 Emelia J. Benjamin United States 341k citations
7 Jun Wang China 340k citations
8 Giuseppe Remuzzi Italy 328k citations
9 John P. A. Ioannidis United States 317k citations
10 Gordon Henry Guyatt Canada 315k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Renal Diseases and Glomerulopathies?

The most cited paper in Renal Diseases and Glomerulopathies is "A New Equation to Estimate Glomerular Filtration Rate" (Andrew S. Levey, Lesley A. Stevens, Christopher H. Schmid et al., 2009), with 26,119 citations. Next come "International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)" (7,231) and "Revised Equations for Estimated GFR From Serum Creatinine in Japan" (6,534).

Most cited papers
#	Paper	Released	Citations
1	A New Equation to Estimate Glomerular Filtration Rate Andrew S. Levey, Lesley A. Stevens, Christopher H. Schmid et al. · Annals of Internal Medicine Open access	5 May 2009	26,119
2	International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) Spiros Miyakis, Michael D. Lockshin, Tatsuya Atsumi et al. · Journal of Thrombosis and Haemostasis Open access	13 Jan 2006	7,231
3	Revised Equations for Estimated GFR From Serum Creatinine in Japan Seiichi Matsuo, Enyu Imai, Masaru Horio et al. · American Journal of Kidney Diseases	2 Apr 2009	6,534
4	Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach Lee A. Hebert, Samir M. Parikh, Jason M. Prosek et al. · American Journal of Nephrology Open access	2013	4,380
5	Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis Kunihiro Matsushita · The Lancet Open access	18 May 2010	4,213

All 99 most cited papers, with filters and sorting

Where is Renal Diseases and Glomerulopathies research done?

The largest centres of Renal Diseases and Glomerulopathies research in 2022-now are Beijing (China), Tokyo (Japan), Shanghai (China) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Little Rock, Rochester and Leicester.

Largest cities, 2022-now

1 BeijingChina 236 works
2 TokyoJapan 177 works
3 ShanghaiChina 118 works
4 GuangzhouChina 114 works
5 ParisFrance 107 works
6 New YorkUnited States 103 works
7 BostonUnited States 87 works
8 LondonUnited Kingdom 85 works
9 HangzhouChina 82 works
10 SeoulSouth Korea 80 works

Where it is the local speciality

Little RockUS · 21.8 works11×
RochesterUS · 31.0 works10×
LeicesterGB · 32.4 works9.2×

← less than its size predicts1×more →

Location quotient: how much more of its research is in Renal Diseases and Glomerulopathies than the world average.

See Renal Diseases and Glomerulopathies on the map

Where is the best place to study Renal Diseases and Glomerulopathies?

Among universities, judged by research, Universität Hamburg, Harvard University and Peking University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged

40%

Specialisationhow much of its work is in this field, counted up to 10× the world share

10%

Sizeits output in this field, on a log scale

30%

Growthoutput growth, counted from -20% to +20%

10%

Internationalshare of its work with a co-author abroad

10%

Each slider sets a weight; the share it gets of the score is beside it.

#	University	Score	Top 10%	Specialisation	Works	Growth
1	Universität HamburgGermany	78.1	27.2%	7.4×	36	+40.5%
2	Harvard UniversityUnited States	76.7	16.5%	3.5×	76	+15.2%
3	Peking UniversityChina	71.0	16.2%	5.2×	72	+20.5%
4	University of LeicesterUnited Kingdom	69.8	21.3%	13.6×	25	+111.7%
5	University of TorontoCanada	66.8	16.4%	2.6×	35	+25.4%
6	Columbia UniversityUnited States	64.9	17.6%	4.2×	31	+3.1%
7	RWTH Aachen UniversityGermany	60.9	24.7%	3.4×	18	+78.2%
8	University of MichiganUnited States	59.0	9.8%	3.2×	32	+52.9%
9	Huazhong University of Science and TechnologyChina	58.6	20.2%	2.6×	32	+81.8%
10	University of Alabama at BirminghamUnited States	58.5	15.8%	6.8×	22	+20.0%
11	Stanford UniversityUnited States	58.0	18.1%	2.1×	21	+117.4%
12	Johns Hopkins UniversityUnited States	57.6	16.3%	2.7×	28	+5.7%
13	University of GroningenNetherlands	57.1	21.8%	3.0×	14	+16.8%
14	Shanghai Jiao Tong UniversityChina	56.8	14.7%	2.3×	45	+51.8%
15	Wuhan UniversityChina	56.7	32.6%	1.4×	13	+82.1%
16	Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina	56.1	15.9%	4.6×	32	+28.1%
17	University of MiamiUnited States	55.5	15.3%	5.2×	22	+56.0%
18	University of WashingtonUnited States	54.9	15.3%	2.4×	18	+18.4%
19	Université Paris CitéFrance	54.0	18.7%	5.1×	26	-33.5%
20	University of CologneGermany	54.0	16.0%	5.6×	16	+35.9%
21	Southern Medical UniversityChina	53.3	16.7%	5.4×	22	+17.2%
22	Shandong UniversityChina	52.9	34.5%	1.0×	9	+41.2%
23	Shanxi Medical UniversityChina	52.3	21.8%	8.8×	14	+92.9%
24	University of Hong KongChina	52.3	20.5%	1.7×	11	+36.7%
25	Nanjing Medical UniversityChina	51.8	10.3%	6.0×	36	+32.6%
26	Zhejiang UniversityChina	51.3	11.7%	2.2×	39	+127.3%
27	The University of SydneyAustralia	51.3	13.2%	2.6×	21	+18.4%
28	Zhejiang Chinese Medical UniversityChina	51.1	15.0%	11.8×	20	+258.9%
29	Yale UniversityUnited States	50.8	10.9%	2.8×	20	+33.0%
30	University of ManchesterUnited Kingdom	50.8	14.0%	2.9×	17	+59.4%
31	University of PennsylvaniaUnited States	50.6	18.5%	2.7×	19	-3.8%
32	University of ZurichSwitzerland	50.6	22.0%	2.1×	10	+62.9%
33	National and Kapodistrian University of AthensGreece	50.4	15.8%	5.2×	18	+20.6%
34	Boston UniversityUnited States	50.0	19.6%	3.0×	10	+43.9%
35	The Ohio State UniversityUnited States	49.9	10.6%	3.6×	30	-4.0%
36	Heidelberg UniversityGermany	49.7	19.2%	2.9×	15	-0.2%
37	Beijing University of Chinese MedicineChina	49.7	17.9%	9.3×	15	+91.6%
38	Fujian Medical UniversityChina	49.5	14.2%	5.8×	21	+98.5%
39	Case Western Reserve UniversityUnited States	49.5	15.3%	3.7×	15	+88.0%
40	University of IowaUnited States	49.3	15.5%	4.4×	14	+29.8%
41	University College LondonUnited Kingdom	49.2	8.0%	2.6×	28	+5.5%
42	Capital Medical UniversityChina	49.1	8.4%	4.8×	34	+49.9%
43	Sun Yat-sen UniversityChina	48.9	8.1%	3.0×	42	+24.3%
44	Juntendo UniversityJapan	46.9	18.8%	20.1×	22	-14.4%
45	Radboud University NijmegenNetherlands	46.8	12.6%	3.9×	16	-10.2%
46	Karolinska InstitutetSweden	45.8	14.2%	3.3×	13	-8.5%
47	All India Institute of Medical SciencesIndia	45.4	2.0%	5.7×	42	+93.6%
48	Chinese University of Hong KongChina	44.9	17.5%	1.7×	8	+55.3%
49	University of Electronic Science and Technology of ChinaChina	43.2	22.7%	1.1×	8	+394.5%
50	Jikei University School of MedicineJapan	42.3	5.3%	34.4×	24	+20.7%
51	Post Graduate Institute of Medical Education and ResearchIndia	41.1	6.5%	10.7×	23	+10.1%
52	Carol Davila University of Medicine and PharmacyRomania	40.7	6.8%	15.3×	16	+36.0%
53	Monash UniversityAustralia	39.6	19.5%	1.4×	9	-1.2%
54	Imperial College LondonUnited Kingdom	38.7	24.2%	1.3×	9	-31.9%
55	University of BergenNorway	38.1	7.5%	4.8×	10	+62.5%
56	Christian Medical College, VelloreIndia	37.9	8.1%	13.6×	12	+31.8%
57	Jawaharlal Institute of Post Graduate Medical Education and ResearchIndia	30.5	4.9%	13.0×	12	+59.0%
58	Tokyo Women's Medical UniversityJapan	24.9	12.6%	18.0×	9	-61.5%
59	SHOWA Medical UniversityJapan	21.6	3.2%	12.6×	8	-7.7%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Renal Diseases and Glomerulopathies, country by country

Is Renal Diseases and Glomerulopathies research growing?

Output in 2022-2025 was 22% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Renal Diseases and Glomerulopathies.

grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Renal Diseases and Glomerulopathies as a percentage of every work published that year, 0.033% in 2024.

Fractional works of Renal Diseases and Glomerulopathies over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Renal Diseases and Glomerulopathies. Posts are plain text and can be reported.

Which countries lead Renal Diseases and Glomerulopathies research?

By volume, 2022-now

How concentrated that is

Which institutions lead Renal Diseases and Glomerulopathies research?

By volume, 2022-now

Who are the leading researchers in Renal Diseases and Glomerulopathies?

What are the most cited papers in Renal Diseases and Glomerulopathies?

Where is Renal Diseases and Glomerulopathies research done?

Largest cities, 2022-now

Where it is the local speciality

Where is the best place to study Renal Diseases and Glomerulopathies?

Is Renal Diseases and Glomerulopathies research growing?

Its share of all research

How much of it reaches the world top 10%

Which topics inside it are moving

Related research

Discussion